Treatment of thromboembolism in cancer patients.

Panova-Noeva M, Falanga A.

Expert Opin Pharmacother. 2010;11(12):2049-58

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management.

Mandalà M, Falanga A, Roila F; ESMO Guidelines Working Group.

Ann Oncol. 2010;21 Suppl 5:v274-6.

Proceedings of the Fifth International Conference on Thrombosis and Hemostasis Issues in Cancer, held in Stresa, Italy, April 23-25, 2010. Preface.

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2010;125 Suppl 2:ix.

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.

Cella G, Marchetti M, Vianello F, Panova-Noeva M, Vignoli A, Russo L, Barbui T, Falanga A.

Thromb Haemost. 2010;104(1):151-6.

Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.

Giordano P, Molinari AC, Del Vecchio GC, Saracco P, Russo G, Altomare M, Perutelli P, Crescenzio N, Santoro N, Marchetti M, De Mattia D, Falanga A.

Am J Hematol. 2010;85(5):325-30.

Video meliora proboque sed deteriora sequor: the case of thromboprophylaxis in hospitalized cancer patients.

Mandala M, Falanga A, Labianca R.

Ann Oncol. 2010;21(5):911-3.

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.

Mandalà M, Barni S, Prins M, Labianca R, Tondini C, Russo L, Milesi A, Cremonesi M, Zaccanelli M, Regonesi C, Moro C, Falanga A.

Ann Oncol. 2010;21(4):871-6.